Carvedilol (Compound)

Synonyms:carvedilol, 72956-09-3, Coreg, Dilatrend, Eucardic, Carvedilolum [Latin], BM 14190, Carvedilolum, 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, SKF 105517, BM-14190, 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol, 1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol, DQ 2466, C24H26N2O4, (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol, CHEMBL723, DQ-2466, CHEBI:3441, [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine, 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol, MFCD00864692, (R)-BM 14190, (S)-BM 14190, Kredex, Querto, BM 14.190, Coropress, Artist, Dibloc, 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol, SMR000449280, Artist (TN), Coreg (TN), HSDB 7044, SR-01000759289, MFCD00869663, 1-(9H-Carbazol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol, Carvedilol D5, C07AG02, EG-P042, Carvedilol - Bio-X, BM14190, Carvedilol [USAN:USP:INN:BAN:JAN], SK&F-105517, Spectrum_001665, BM-14-190, BM-14.190, Spectrum2_001673, Spectrum3_001182, Spectrum4_000636, Spectrum5_001436, SCHEMBL22293, GTPL551, KBioGR_001252, KBioSS_002145, MLS000758299, MLS000759508, MLS001424092, MLS006011886, SPBio_001885, Carvedilol (JP17/USP/INN), DTXSID8022747, SCHEMBL10082334, SCHEMBL13287211, BDBM25759, KBio2_002145, KBio2_004713, KBio2_007281, KBio3_002323, (R)-1-[(4-Carbazolyl)oxy]-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, HMS2051N03, HMS2089B09, HMS2093E12, HMS3261E15, HMS3269N11, HMS3393N03, HMS3413B14, HMS3655O14, HMS3677B14, HMS3715D15, HMS3750I15, HMS3884E12, Pharmakon1600-01504257, Carvedilol 1.0 mg/ml in Methanol, ((c)I)-Carvedilol-d4(ethyl-d4), AMY40801, BCP23386, EX-A5746, HY-B0006, Tox21_500347, BBL029064, MFCD00869664, NSC758694, s1831, STK621453, AKOS005554967, Carvedilol, >=98% (HPLC), solid, AC-1641, BCP9000493

Pubchem:PUBCHEM:2585

Id:2585

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Carvedilol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Carvedilol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Carvedilol.

Results found

Linked to

	Label	Description
	BRD-A10977446-001-05-5 Substance (Entity type)	A Substance
	carvedilol (ab9c6ef8-b3d0-4412-9d6a-c0e336a45fdd) Collection (Entity type)	Metadatata for carvedilol
	DCSTRUCT ID 00522 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00522; PubChem_CID:2585, FILE=drugcentral_drug_00522.json)
	Carvedilol negatively regulates DDX42 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol negatively regulates PROM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol positively regulates UCHL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol negatively regulates ZNF331 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol bioactivity Potassium channel subfamily K member 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Carvedilol negatively regulates HLA-DQA1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Carvedilol bioactivity 5-hydroxytryptamine receptor 2B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG